For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Scope of the Report:
In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.
The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.
The worldwide market for Botulinum Toxins is expected to grow at a CAGR of roughly 13.3% over the next five years, will reach 8500 million US$ in 2024, from 4550 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Botulinum Toxins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Merz Pharmaceuticals
- US World Meds
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Botulinum Toxins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Botulinum Toxins, with price, sales, revenue and global market share of Botulinum Toxins in 2017 and 2018.
Chapter 3, the Botulinum Toxins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Botulinum Toxins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Botulinum Toxins market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Botulinum Toxins sales channel, distributors, customers, research findings and conclusion, appendix and data source.